Your browser doesn't support javascript.
loading
Molecular Imaging of PD-1 Unveils Unknown Characteristics of PD-1 Itself by Visualizing "PD-1 Microclusters".
Nishi, Wataru; Wakamatsu, Ei; Machiyama, Hiroaki; Matsushima, Ryohei; Yoshida, Yosuke; Nishikawa, Tetsushi; Toyota, Hiroko; Furuhata, Masae; Nishijima, Hitoshi; Takeuchi, Arata; Suzuki, Makoto; Yokosuka, Tadashi.
Afiliação
  • Nishi W; Department of Thoracic Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Wakamatsu E; Department of Immunology, Tokyo Medical University, Tokyo, Japan.
  • Machiyama H; Department of Immunology, Tokyo Medical University, Tokyo, Japan.
  • Matsushima R; Department of Immunology, Tokyo Medical University, Tokyo, Japan.
  • Yoshida Y; Department of Thoracic Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Nishikawa T; Department of Immunology, Tokyo Medical University, Tokyo, Japan.
  • Toyota H; Department of Immunology, Tokyo Medical University, Tokyo, Japan.
  • Furuhata M; Department of Nephrology, Tokyo Medical University, Tokyo, Japan.
  • Nishijima H; Department of Immunology, Tokyo Medical University, Tokyo, Japan.
  • Takeuchi A; Department of Dermatology, Tokyo Medical University, Tokyo, Japan.
  • Suzuki M; Department of Immunology, Tokyo Medical University, Tokyo, Japan.
  • Yokosuka T; Department of Immunology, Tokyo Medical University, Tokyo, Japan.
Adv Exp Med Biol ; 1444: 197-205, 2024.
Article em En | MEDLINE | ID: mdl-38467981
ABSTRACT
Programmed cell death-1 (PD-1) is one of the most famous coinhibitory receptors that are expressed on effector T cells to regulate their function. The PD-1 ligands, PD-L1 and PD-L2, are expressed by various cells throughout the body at steady state and their expression was further regulated within different pathological conditions such as tumor-bearing and chronic inflammatory diseases. In recent years, immune checkpoint inhibitor (ICI) therapies with anti-PD-1 or anti-PD-L1 has become a standard treatment for various malignancies and has shown remarkable antitumor effects. Since the discovery of PD-1 in 1992, a huge number of studies have been conducted to elucidate the function of PD-1. Herein, this paper provides an overview of PD-1 biological findings and sheds some light on the current technology for molecular imaging of PD-1.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article